EFFICACY AND SAFETY OF FINERENONE IN PATIENTS WITH NEPHRECTOMY: A FIDELITY SUBANALYSIS

  Back
EFFICACY AND SAFETY OF FINERENONE IN PATIENTS WITH NEPHRECTOMY: A FIDELITY SUBANALYSIS
E-Poster Presentation

During the congress, E-Posters will be accessible to all participants on the congress website 24/7, as well as in the E-poster stations in the congress center. 

Preparing your E-Poster

Please review the E-Poster format requirements carefully when preparing your E-Poster. Should your E-Poster not meet the mentioned requirements, it may not be displayed as described above.

​E-Poster Submission Deadline

Please prepare and upload your E-Poster no later than January 23, 2025. After this date, you will no longer be able to prepare and upload your E-poster and it will not be displayed and accessible on the congress website.​

E-Poster Format Requirements
  • PDF file
  • Layout: Portrait (vertical orientation)
  • One page only (Dim A4: 210 x 297mm or PPT)
  • E-Poster can be prepared in PowerPoint (one (1) PowerPoint slide) but must be saved and submitted as PDF file.
  • File Size: Maximum file size is 2 Megabytes (2 MB)
  • No hyperlinks, animated images, animations, and slide transitions
  • Language: English
  • Include your abstract number
  • E-posters can include QR codes, tables and photos
https://storage.unitedwebnetwork.com/files/1099/cb7154cc2456167d6ec643face428d02.pdf
Katja
Rohwedder
10
Jair Munoz Mendoza JMMendoza@med.miami.edu UNIVERSITY OF MIAMI Medicine Miami United States
Matthew Weir Mweir@som.umaryland.edu University of Maryland School of Medicine Department of Medicine Baltimore United States
Stefan D. Anker s.anker@cachexia.de Charité Universitätsmedizin Department of Cardiology of German Heart Center Charité Berlin Germany
Gerasimos Filippatos gfilippatos@gmail.com National and Kapodistrian University of Athens Department of Cardiology Athens Greece
Peter Rossing peter.rossing@regionh.dk Steno Diabetes Center Copenhagen Denmark
Christiane Ahlers christiane.ahlers@bayer.com Bayer AG Statistics and Data Insights Wuppertal Germany
Meike Brinker meike.brinker@bayer.com Bayer AG Cardiology and Nephrology Clinical Development Wuppertal Germany
Samuel T. Fatoba samuel.fatoba@bayer.com Bayer US LLC, Medical Affairs Whippany United States
Andrea Horvat-Broecker andrea.horvat-broecker@bayer.com Bayer AG Medical Affairs and Pharmacovigilance Wuppertal Germany
Katja Rohwedder katja.rohwedder@bayer.com Bayer AG Cardio-Renal Medical Affairs Department Berlin Germany
Alessia Fornoni AFornoni@med.miami.edu University of Miami Department of Medicine Miami United States